Exploratory study on predictive biomarkers for anti-HER2 drugs in breast cancer

Not Applicable

Recruiting

• Conditions: HER2 positive breast cancer

• Registration Number: JPRN-UMIN000010797
• Lead Sponsor: Ministry of Education, Culture Sports, Science and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-05-24
• Study Completion: 2017-05-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To correlate the presence of somatic mutations in cancer cells and drug efficacy